- Home
- BCBP vs VIGL Comparison
BCBP vs VIGL Comparison
Compare BCBP & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCBP
- VIGL
- Stock Information
- Founded
- BCBP 2000
- VIGL 2020
- Country
- BCBP United States
- VIGL United States
- Employees
- BCBP N/A
- VIGL N/A
- Industry
- BCBP Savings Institutions
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- BCBP Finance
- VIGL Health Care
- Exchange
- BCBP Nasdaq
- VIGL Nasdaq
- Market Cap
- BCBP 186.8M
- VIGL 95.2M
- IPO Year
- BCBP N/A
- VIGL 2022
- Fundamental
- Price
- BCBP $11.66
- VIGL $1.78
- Analyst Decision
- BCBP Hold
- VIGL Strong Buy
- Analyst Count
- BCBP 2
- VIGL 5
- Target Price
- BCBP $13.75
- VIGL $19.75
- AVG Volume (30 Days)
- BCBP 52.7K
- VIGL 305.8K
- Earning Date
- BCBP 01-23-2025
- VIGL 11-07-2024
- Dividend Yield
- BCBP 5.81%
- VIGL N/A
- EPS Growth
- BCBP N/A
- VIGL N/A
- EPS
- BCBP 1.17
- VIGL N/A
- Revenue
- BCBP $89,636,000.00
- VIGL N/A
- Revenue This Year
- BCBP N/A
- VIGL N/A
- Revenue Next Year
- BCBP $6.60
- VIGL N/A
- P/E Ratio
- BCBP $9.42
- VIGL N/A
- Revenue Growth
- BCBP N/A
- VIGL N/A
- 52 Week Low
- BCBP $9.19
- VIGL $1.49
- 52 Week High
- BCBP $14.04
- VIGL $6.06
- Technical
- Relative Strength Index (RSI)
- BCBP 41.35
- VIGL 40.73
- Support Level
- BCBP $10.64
- VIGL $1.49
- Resistance Level
- BCBP $11.97
- VIGL $2.10
- Average True Range (ATR)
- BCBP 0.30
- VIGL 0.17
- MACD
- BCBP -0.03
- VIGL 0.06
- Stochastic Oscillator
- BCBP 55.32
- VIGL 47.54
About BCBP BCB Bancorp Inc. (NJ)
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection, and automated teller services.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.